You are here » Home » Companies » Company Overview » Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd.

BSE: 524742 Sector: Health care
NSE: CAPLIPOINT ISIN Code: INE475E01026
BSE LIVE 14:59 | 29 Mar 386.90 3.70
(0.97%)
OPEN

383.95

HIGH

390.75

LOW

382.20

NSE LIVE 15:04 | 29 Mar 385.80 1.95
(0.51%)
OPEN

384.95

HIGH

389.95

LOW

382.50

OPEN 383.95
PREVIOUS CLOSE 383.20
VOLUME 3387
52-Week high 459.70
52-Week low 184.00
P/E 44.32
Mkt Cap.(Rs cr) 2924.96
Buy Price 384.80
Buy Qty 27.00
Sell Price 386.85
Sell Qty 23.00
OPEN 383.95
CLOSE 383.20
VOLUME 3387
52-Week high 459.70
52-Week low 184.00
P/E 44.32
Mkt Cap.(Rs cr) 2924.96
Buy Price 384.80
Buy Qty 27.00
Sell Price 386.85
Sell Qty 23.00

Caplin Point Laboratories Ltd. (CAPLIPOINT) - Company History

Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. The company came out with a public issue in Nov.'94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. The company entered into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India. The company has established a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also established a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US.